Singapore proteomics market was valued at $21.12 billion in 2019, and
is projected to reach $49.97 billion by 2027 at a CAGR of 12.2% from 2020 to
2027. Proteomics has the capacity to explain questions that were unsolved by
genomics, as proteins are the functional unit of cells. Advancements in
technologies such as mass spectrometry and chromatography and development of
computer algorithms for database searching facilitate proteomics research. The
analysis of target proteins for disease diagnosis is the largest application of
proteomics.
𝗚𝗲𝘁 𝗗𝗲𝘁𝗮𝗶𝗹𝗲𝗱
𝐑𝐞𝐩𝐨𝐫𝐭
https://www.alliedmarketresearch.com/proteomics-market
Most Singapore markets are dropping down as COVID-19 outbreak has
negatively affected various healthcare related markets. The development of
therapeutic and preventive strategies requires an accurate understanding of the
role that proteins play in the SARS-CoV-2 infection process and progression of
COVID-19. A wide array of identification and separation techniques can isolate
proteins from complex mixtures, facilitating the analysis of protein-protein
interactions, temporal expression patterns and cellular or subcellular
distribution. For instance, most common separation methods are one- and
two-dimensional gel electrophoresis and high-performance liquid chromatography,
whereas mass spectrometry (MS) forms the backbone of protein detection and
identification. MS-based detection can provide simple and rapid detection of
SARS-CoV-2, even among recovered patients. Hence, in the perspective of
COVID-19, proteomics can help to reveal novel biomarkers and define
point-of-care procedures that could mean cost-effective healthcare can be
delivered closer to the patient.
The key drivers of the proteomics market include increased
in popularity of personalized medicines, surge in R&D expenditure and
technological advancements associated with proteomics components. Moreover,
high costs associated with proteomics components and dearth of skilled
professionals hamper the market growth. Conversely lucrative opportunities
associated with biomarker identification and developments in mass
spectrometry-based proteomics are expected to provide lucrative proteomics
market growth opportunities.
The protein microarray segment generated the highest revenue
in 2019 in the proteomics instruments market, owing to high usage of this
technology to track protein interactions in lesser time as compared to other
technologies. Moreover, this method is labor-intensive and cost-effective. With
the help of protein array, the comprehensive information about the DNA/RNA
binding proteins can be made available.
By reagents segment, immunoassays held the highest
proteomics market share in the total market, as they are extensively utilized
in primary screening in drug discovery and microarray technologies. On the
basis of application, the drug discovery segment accounted for the majority
market share in 2019, owing to increase in awareness of personalized medicines
in both emerging and developed markets, thereby boosting the Singapore proteomics market
growth in coming years.
North America held the largest proteomics market share of
nearly 39.0% of the total market in 2019, due to increase in popularity and
adoption of personalized medicines and favorable government funding &
initiatives to develop novel therapeutics. However, Asia-Pacific is expected to
grow at a CAGR of 15.6% from 2019 to 2027, owing to rise in prevalence of
chronic diseases and increase in interest of researchers to utilize proteomics
in disease diagnosis & treatment.
The Singapore proteomics market is segmented on the basis of
component, application, and region. On the basis of component, the market is
categorized into reagents, instruments, and services. The reagents segment is
further classified into microarray, spectrometry, X-ray crystallography,
chromatography, electrophoresis, immunoassay, and protein fractionation
reagents. Likewise, the proteomics instruments segment is sub segmented into
protein microarray, spectrometry, chromatography, electrophoresis, surface
plasmon resonance, X-ray crystallography, and protein fractionation systems.
The spectrometry segment is subdivided into mass spectrometry and NMR
spectrometry. Similarly, the chromatography segment is sub classified into HPLC
systems, ion chromatography, affinity chromatography, and supercritical fluid
chromatography. The applications covered in the study include drug discovery,
disease diagnosis, and others. Region wise, the proteomics market is analyzed
across North America, Europe, Asia-Pacific, and LAMEA.
0 Comments